SAN FRANCISCO, Jan. 8 – In its latest attempt to kill Pharmacopeia's acquisition of Eos Biotechnology, OrbiMed Advisors, a financial services firm that owns the greatest single stake in Pharmacopeia stock, on Tuesday urged shareholders to follow its lead and vote against the proposed deal.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.